My Prostate Cancer Story: Robert Cunningham
How far would you go to protect yourself and your family? What if it was a matter of life and death? And what if the answer was a simple exam? Like many, Robert Cunningham of Richmond, Virginia would do just about anything for his family. When he lost his grandfather. Read More
PCF Champion: Ryan Brown
To honor his grandfather, who passed away in January, an extraordinary 12-year-old boy took on the entire NFL to raise awareness for prostate cancer. Read More
My Prostate Cancer Story: Brian Custer
“Do you want to live or do you want to die?” That’s a question Brian Custer asks men, especially African-American men, when they aren’t sure whether to get checked for prostate cancer. Read More
10/13/2016
My Prostate Cancer Story: Muhit Rahman
“It’s always life-altering to hear that you have cancer. Until you get that news, you don’t have cancer. And then all of a sudden, you do.” Read More
New Clinical Trial Methods Accelerate Research and Development
Prostate cancer can be slow to progress, frustrating the development of new therapies for patients with early, high-risk disease. New results from ICECaP (Intermediate Clinical Endpoints for Cancer of the Prostate), a PCF-supported initiative led by Dr. Christopher Sweeney, will cut the time required to assess new therapies for aggressive. Read More
Interview with an Expert: Active Surveillance
Christopher Barbieri, M.D., Ph.D. Assistant Professor, Urology Assistant Professor, Cell and Developmental Biology Weill Cornell Medicine New York Presbyterian Medical Center “There’s no one way to select candidates for active surveillance,” says urologist and molecular biologist Chris Barbieri, M.D., Ph.D., who treats men with all kinds of prostate cancer and. Read More
Active Surveillance: What You Need to Know
Is active surveillance right for you? The answer to this question varies, depending on a bunch of factors: your particular form of prostate cancer, your age and general health, and also on the criteria used to select men for active surveillance programs from hospital to hospital. First, what is active. Read More
A Not-So-Good Practice Proves Harmful in African-American Men
It wasn’t that great of an idea to start with: giving hormonal therapy to lower testosterone in men with localized prostate cancer to make them eligible for radiation seed treatment. The idea is that a short course of hormonal therapy – usually a shot of Lupron or Zoladex – will. Read More
10/12/2016
For Some Advanced Cancers, What Might be Cures
We may have turned the corner. We’re not there yet, but wow, are we hopeful! At the Prostate Cancer Foundation, our goal has always been to put ourselves out of business by curing this terrible disease. Not just by catching it early, or by curing cancer that’s confined to the. Read More
Genes that Discriminate
“African-American men are discriminated against by prostate cancer, and for the first time, we know why.” This was oncologist Jonathan Simons, M.D., CEO of the Prostate Cancer Foundation, talking to the Congressional Black Caucus at a special symposium on prostate cancer. Simons was telling the lawmakers about the trailblazing work. Read More